Ammonia metabolism,the brain and fatigue; revisiting the link |
| |
Authors: | Daniel J. Wilkinson Nicholas J. SmeetonPeter W. Watt |
| |
Affiliation: | Department of Sport and Exercise Science, Chelsea School, University of Brighton, 30 Carlisle Road, Eastbourne, BN20 7SP, UK |
| |
Abstract: | This review addresses the ammonia fatigue theory in light of new evidence from exercise and disease studies and aims to provide a view of the role of ammonia during exercise. Hyperammonemia is a condition common to pathological liver disorders and intense or exhausting exercise. In pathology, hyperammonemia is linked to impairment of normal brain function and the onset of the neurological condition, hepatic encephalopathy. Elevated blood ammonia concentrations arise due to a diminished capacity for removal via the liver and lead to increased exposure of organs, such as the brain, to the toxic effects of ammonia. High levels of brain ammonia can lead to deleterious alterations in astrocyte morphology, cerebral energy metabolism and neurotransmission, which may in turn impact on the functioning of important signalling pathways within the neuron. Such changes are believed to contribute to the disturbances in neuropsychological function, in particular the learning, memory, and motor control deficits observed in animal models of liver disease and also patients with cirrhosis. Hyperammonemia in exercise occurs as a result of an increased production by contracting muscle, through adenosine monophosphate (AMP) deamination (the purine nucleotide cycle) and branched chain amino acid (BCAA) deamination prior to oxidation. Plasma concentrations of ammonia during exercise often achieve or exceed those measured in liver disease patients, resulting in increased cerebral uptake. In this article we propose that exercise-induced hyperammonemia may lead to concomitant disturbances in brain function, potentially through similar mechanisms underpinning pathology, which may impact on performance as fatigue or reduced function, especially during extreme exercise. |
| |
Keywords: | AAT, alanine amino transferase ADP, adenosine diphosphate AK, adenylate kinase AL, adenylosuccinate lyase Ala, alanine ALC, acetyl-L-carnitine AMP, adenosine monophosphate AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionate AMPD, AMP deaminase Arg, arginine AS, adenylosuccinate synthetase ATP, adenosine triphosphate a-v diff, arterio-venous difference BBB, blood brain barrier BCAA, branched chain amino acid BCAT, branched-chain amino transferase BCKDH, branched chain keto-acid dehydrogenase BCKA, branched chain keto-acids CBF, cerebral blood flow cGMP, cyclic guanosine monophosphate Cm, calmodulin CNS, central nervous system CoA-SH, coenzyme A reduced form CPCCOEt, 7-hydroxyiminocyclopropan[b]chromen-la-carboxylic acid ethyl ester CPF, cerebral plasma flow CSF, cerebrospinal fluid DHPG, (5)-3,5-dihydroxyphenylglycine EAA, essential amino acid EEG, electroencephalogram ERP, event-related brain potential fMRI, functional magnetic resonance imaging GABA, gamma-aminobutyric acid GDH, glutamate dehydrogenase GDP, guanosine diphosphate GI Tract, gastrointestinal tract Glu, glutamate Gluc, glucose Gluc-6-P, glucose-6-phosphate Gln, glutamine GS, glutamine synthetase GTP, guanosine triphosphate HCO3&minus , bicarbonate ion HE, hepatic encephalopathy IMP, inosine monophosphate K+, potassium ion Kinase, BCKDH kinase LTP, long term potentiation MDT, medio-dorsal thalamus mGluR, metabotropic glutamate receptor MPT, mitochondrial permeability transition NA, nucleus accumbens NAD+, nicotinamide adenine dinucleotide NADH, nicotinamide adenine dinucleotide hydrate NH3, ammonia gaseous form NH4+, ammonium ion NMDA, N-methyl-D-aspartate NO, nitric oxide NOS, nitric oxide synthetase nNOS, neuronal nitric oxide synthetase OP, l-ornithine phenylacetate OTC, ornithine trancarbamoylase PAG, phosphate activated glutaminase PCS, portacaval shunt PDE, phosphodiesterase PET, positron emission tomography PFCx, prefrontal cortex Phos, BCKDH phosphotase PKG, protein kinase G PKC, protein kinase C PLC, phospholipase C PNC, purine nucleotide cycle Pyr, pyruvate R-CoA, acyl coenzyme A RhB(C)G, rhesus non-erythroid glycoprotein B (C) ROS, reactive oxygen species SNr, substantia nigra pars reticulata sGC, soluble guanylate cyclase SNAP, S-nitroso-N-acetyl-pencillamine VMT, ventro-medial thalamus VP, ventral pallidum |
本文献已被 ScienceDirect 等数据库收录! |
|